Biospecifics Technologies Corp Receivables Turnover Ratio (BSTC), from the third quarter 2020 to the third quarter 2019 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Biospecifics Technologies Corp  (NASDAQ: BSTC)
 

Biospecifics Technologies Accounts Receivables Turnover Ratio from the third quarter 2020 to the third quarter 2019

Quarterly Results, Trends, Rankings, Statistics


Biospecifics Technologies Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2020 to a ratio of 2.36, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Biospecifics Technologies in Sep 30 2020 quarter, has decreased to 155 days, compared to 174 days, in the Jun 30 2020 quarter.

If we take a look into Healthcare sector 507 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2020 from 2596 to 3380.

What is Receivable Turnover Ratio?
What is Biospecifics Technologies Corp Selling?


What is Receivable Turnover Ratio?





BSTC Receivables Turnover Ratio (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Receivable Change -23.5 % -30.08 % 7.73 % 15.42 % 22.92 %
Y / Y Revenue Change 19.21 % -55.91 % 18.94 % 10.9 % 15.6 %
Receivable Turnover Ratio (TTM) 2.36 2.1 2.23 2.18 2.19
BSTC's Total Ranking # 3380 # 2596 # 3376 # 3380 # 3374
Accounts Receivable average collection period days 155 174 164 167 166
Seq. Receivable Change 16.22 % -34.11 % -6.9 % 7.3 % 6.21 %
Seq. Revenue Change 188.36 % -59.63 % -17.81 % 24.58 % 6.66 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 198
Healthcare Sector # 508
Overall Market # 3380

Receivable Turnover Ratio Statistics
High Average Low
6.12 3.83 2.09
(Sep 30 2017)   (Dec 31 2018)






Financial Statements
Biospecifics Technologies's Accounts Receivable $ 14 Millions Visit BSTC's Balance sheet
Biospecifics Technologies's Sales TTM $ 37 Millions Visit BSTC's Income Statement
Sources of BSTC's Revenues Visit BSTC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BSTC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BSTC's Growth Rates BSTC's Roa BSTC's Inventory Turnover Ratio BSTC's Dividend Comparisons
BSTC's Profitability Ratios BSTC's Roi BSTC's Asset Turnover Ratio BSTC's Dividend Growth
BSTC's Valuation Ratios BSTC's Roe BSTC's Financial Strength Ratios BSTC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2020 Receivable at quarter ending Sep 30 2020
Star Equity Holdings Inc   7.38 $ 117.694  Millions$ 15.945  Millions
Shockwave Medical Inc   7.36 $ 59.386  Millions$ 8.066  Millions
Wright Medical Group N v   7.35 $ 970.174  Millions$ 131.974  Millions
Dermtech Inc   7.32 $ 6.562  Millions$ 0.896  Millions
Atrion Corporation  7.32 $ 149.813  Millions$ 20.472  Millions
Quest Diagnostics Inc  7.30 $ 8,361.000  Millions$ 1,145.500  Millions
Escalon Medical Corp   7.27 $ 9.526  Millions$ 1.311  Millions
Igc Pharma Inc   7.26 $ 1.311  Millions$ 0.181  Millions
Vycor Medical Inc   7.26 $ 1.226  Millions$ 0.169  Millions
Lantheus Holdings Inc   7.25 $ 334.604  Millions$ 46.125  Millions
Prestige Consumer Healthcare Inc   7.25 $ 959.603  Millions$ 132.388  Millions
Edwards Lifesciences Corporation  7.21 $ 4,368.700  Millions$ 605.950  Millions
Sanuwave Health Inc   7.20 $ 3.035  Millions$ 0.421  Millions
Gw Pharmaceuticals Plc  7.18 $ 488.059  Millions$ 67.968  Millions
Neurocrine Biosciences Inc   7.18 $ 1,042.010  Millions$ 145.119  Millions
Masimo Corp  7.18 $ 1,096.200  Millions$ 152.754  Millions
Seagen Inc   7.14 $ 1,864.047  Millions$ 261.026  Millions
Chinook Therapeutics Inc   7.13 $ 26.944  Millions$ 3.778  Millions
Nrc Health  7.12 $ 131.126  Millions$ 18.407  Millions
Kushco Holdings Inc   7.10 $ 114.046  Millions$ 16.059  Millions
Organogenesis Holdings Inc   7.08 $ 306.136  Millions$ 43.256  Millions
Exelixis Inc   7.05 $ 957.796  Millions$ 135.907  Millions
Magellan Health inc   7.03 $ 5,867.156  Millions$ 834.001  Millions
Biogen Inc   7.02 $ 14,263.300  Millions$ 2,032.900  Millions
Pacific Biosciences Of California Inc   6.97 $ 79.687  Millions$ 11.436  Millions
Capricor Therapeutics inc   6.94 $ 0.475  Millions$ 0.068  Millions
Biolife Solutions Inc   6.94 $ 41.657  Millions$ 5.999  Millions
Inspire Medical Systems inc   6.94 $ 96.278  Millions$ 13.875  Millions
Retractable Technologies Inc  6.93 $ 62.496  Millions$ 9.020  Millions
Lemaitre Vascular Inc   6.92 $ 121.988  Millions$ 17.631  Millions

Date modified: 2026-08-29T17:26:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.